We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
-4.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$11.8B
AUM Growth
+$1.34B
(+13%)
Cap. Flow
+$2.18B
Cap. Flow
% of AUM
18.39%
Top 10 Holdings %
Top 10 Hldgs %
3.51%
Holding
4,052
New
613
Increased
1,643
Reduced
1,246
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$34.6M |
| 2 |
Workday
WDAY
|
+$33.5M |
| 3 |
FRC
First Republic Bank
FRC
|
+$31.8M |
| 4 |
Zoetis
ZTS
|
+$31.3M |
| 5 |
Synchrony
SYF
|
+$31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$35.7M |
| 2 |
Honeywell
HON
|
+$31.7M |
| 3 |
International Paper
IP
|
+$30.5M |
| 4 |
Archer Daniels Midland
ADM
|
+$23.8M |
| 5 |
Emerson Electric
EMR
|
+$22.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.12% |
| 2 | Financials | 17.75% |
| 3 | Healthcare | 12.17% |
| 4 | Consumer Discretionary | 11.8% |
| 5 | Industrials | 11.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
SLM Corp
SLM
$5.19B
| $417K | ﹤0.01% |
22,707
-11,071
| -33% | -$209K |
|
2652
Ternium
TX
$10.8B
| $416K | ﹤0.01% |
9,119
+4,519
| +98% | +$192K |
|
|
DNMR
2653
DELISTED
Danimer Scientific, Inc.
DNMR
| $416K | ﹤0.01% |
1,773
-2,612
| -60% | -$527K |
|
2654
Valmont Industries
VMI
$9.52B
| $415K | ﹤0.01% |
1,738
+884
| +104% | +$201K |
|
|
MORF
2655
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $413K | ﹤0.01% |
10,287
-4,030
| -28% | -$169K |
|
|
EBIX
2656
DELISTED
Ebix Inc
EBIX
| $413K | ﹤0.01% |
+12,453
| New | +$389K |
|
2657
Allegiant Air
ALGT
$2.34B
| $412K | ﹤0.01% |
2,535
+706
| +39% | +$119K |
|
2658
AEON Biopharma
AEON
$13.6M
| $410K | ﹤0.01% |
583
+251
| +76% | +$176K |
|
|
HSKA
2659
DELISTED
Heska Corp
HSKA
| $408K | ﹤0.01% |
2,954
-584
| -17% | -$82.6K |
|
2660
Vertiv
VRT
$113B
| $406K | ﹤0.01% |
28,994
-43,409
| -60% | -$772K |
|
|
ALTR
2661
DELISTED
Altair Engineering Inc
ALTR
| $406K | ﹤0.01% |
+6,302
| New | +$398K |
|
|
SHCR
2662
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $406K | ﹤0.01% |
164,550
-15,313
| -9% | -$50.3K |
|
2663
Oric Pharmaceuticals
ORIC
$1.42B
| $404K | ﹤0.01% |
+75,599
| New | +$681K |
|
|
PRO
2664
DELISTED
PROS Holdings
PRO
| $404K | ﹤0.01% |
12,123
+2,235
| +23% | +$68.7K |
|
|
ZYXI
2665
DELISTED
Zynex
ZYXI
| $404K | ﹤0.01% |
64,887
+21,521
| +50% | +$151K |
|
|
EIGR
2666
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $404K | ﹤0.01% |
1,622
+1,342
| +479% | +$212K |
|
|
DRE
2667
DELISTED
Duke Realty Corp.
DRE
| $404K | ﹤0.01% |
6,956
-5,707
| -45% | -$323K |
|
|
GES
2668
DELISTED
Guess Inc
GES
| $403K | ﹤0.01% |
18,430
+9,834
| +114% | +$213K |
|
2669
HUTCHMED
HCM
$2.15B
| $403K | ﹤0.01% |
+21,323
| New | +$543K |
|
2670
Olema Pharmaceuticals
OLMA
$915M
| $402K | ﹤0.01% |
94,290
+9,092
| +11% | +$50.1K |
|
2671
DXP Enterprises
DXPE
$3.05B
| $401K | ﹤0.01% |
14,813
+6,548
| +79% | +$186K |
|
|
SILK
2672
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $401K | ﹤0.01% |
+9,700
| New | +$341K |
|
|
SGEN
2673
DELISTED
Seagen Inc. Common Stock
SGEN
| $401K | ﹤0.01% |
2,787
-41,549
| -94% | -$5.62M |
|
2674
SI-BONE Inc
SIBN
$834M
| $399K | ﹤0.01% |
17,674
-9,053
| -34% | -$188K |
|
|
ZEV
2675
DELISTED
Lightning eMotors, Inc.
ZEV
| $398K | ﹤0.01% |
3,490
-2,433
| -41% | -$262K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q1 2022 Portfolio in Review
As of Q1 2022, Cubist Systematic Strategies held 4,052 positions worth $11.8B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
Cubist Systematic Strategies deployed $2.18B of net new capital in Q1 2022, opening 613 new positions and adding to 1,643 existing holdings. Its largest new stake was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Medtronic, an estimated $35.7M trimmed.
- Cubist Systematic Strategies's largest Q1 2022 buy was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
- Cubist Systematic Strategies added most to Abbott in Q1 2022, an estimated $34.6M increase.
- Cubist Systematic Strategies's biggest Q1 2022 reduction was Medtronic, cutting an estimated $35.7M.
- Cubist Systematic Strategies fully exited Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant in Q1 2022, selling an estimated $20.6M.
- Cubist Systematic Strategies's ten largest holdings make up 3.5% of its $11.8B portfolio in Q1 2022.
- Cubist Systematic Strategies opened 613 new positions and closed 518 in Q1 2022.
- Cubist Systematic Strategies's portfolio value rose 13% quarter-over-quarter to $11.8B.
Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.